4-iodoamphetamine has been researched along with Alzheimer Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandt, J; Burns, A; Folstein, MF; Frost, JJ; Harris, G; Mayberg, H; Sapp, J; Steele, C; Tune, L; Wagner, HN | 1 |
Besson, JA; Best, PV; Crawford, JR; Ebmeier, KP; Gemmell, HG; Parker, DM; Sharp, PF; Smith, FW | 1 |
Heironimus, JD; Timmons, JH | 1 |
Cohen, MB; Graham, LS; Yamada, LS | 1 |
Collier, BD; Goldstein, MD; Harsch, HH; Hellman, RS; Tikofsky, RS | 1 |
1 review(s) available for 4-iodoamphetamine and Alzheimer Disease
Article | Year |
---|---|
[123I]iodoamphetamine SPECT imaging.
Topics: Alzheimer Disease; Amphetamines; Animals; Cerebrovascular Disorders; Dementia; Epilepsy; Humans; Iodine Radioisotopes; Tomography, Emission-Computed | 1986 |
1 trial(s) available for 4-iodoamphetamine and Alzheimer Disease
Article | Year |
---|---|
Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
Topics: Aged; Alzheimer Disease; Amphetamines; Blood Glucose; Brain; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Physostigmine; Pilot Projects; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
3 other study(ies) available for 4-iodoamphetamine and Alzheimer Disease
Article | Year |
---|---|
Multimodal imaging in Alzheimer's disease. The relationship between MRI, SPECT, cognitive and pathological changes.
Topics: Aged; Alzheimer Disease; Amphetamines; Blood Flow Velocity; Brain; Cerebral Arteries; Cerebral Cortex; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Oximes; Psychometrics; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1990 |
Coexistence of Alzheimer's disease and multi-infarct dementia diagnosed by functional brain imaging with SPECT.
Topics: Alzheimer Disease; Amphetamines; Dementia, Multi-Infarct; Humans; Tomography, Emission-Computed, Single-Photon | 1990 |
CT, magnetic resonance imaging, and SPECT iodine-123 iodoamphetamine imaging of a patient with progressive cognitive deterioration.
Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1987 |